|
Volumn 14, Issue 4 II, 2000, Pages 421-426
|
Mycophenolate mofetil, with cyclosporine and prednisone, reduces early rejection while allowing the use of less antilymphocytic agent induction and cyclosporine in renal recipients with delayed graft function
a a a a b a a a a |
Author keywords
Antilymphocytic agent induction; Cyclosporine; Immunosuppression; Kidney transplantation; Mycophenolate mofetil; Rejection
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
THYMOCYTE ANTIBODY;
ADOLESCENT;
ADULT;
AGE;
AGED;
ARTICLE;
CADAVER DONOR;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIALYSIS;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HIGH RISK PATIENT;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RACE;
RECIPIENT;
SURVIVAL RATE;
|
EID: 0033916569
PISSN: 09020063
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1399-0012.2000.14041102.x Document Type: Article |
Times cited : (12)
|
References (35)
|